Home » Topics » BioWorld Science, Endocrine/metabolic

BioWorld Science, Endocrine/metabolic
RSS

Dual calcitonin and amylin receptor agonists show potential for obesity, diabetes and osteoarthritis

July 7, 2014

Manganese porphyrin antioxidant ameliorates experimental type 2 diabetes

July 7, 2014

Novel GLP-1 agonist TTP-273 reduces glucose levels in type 2 diabetes patients

July 7, 2014

PKC, a potential target for NAFLD-related hepatic insulin resistance in type 2 diabetes

July 4, 2014

DGAT1 inhibitor protects beta-cell function under nutrient overload

July 4, 2014

Ultragenyx initiates pediatric X-linked hypophosphatemia trial for KRN-23

July 4, 2014

Synageva BioPharma reports topline data from phase III study of sebelipase alfa

July 3, 2014

FOXO1 as a potential therapeutic target for diabetes demonstrated with AS-1842856

July 3, 2014

Osteogenesis improved in patients with hypophosphatasia

July 3, 2014

ISIS-GCGRRx improves glycemic control in type 2 diabetes trial

July 2, 2014

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 8, 2026.
Hengrui discovers new Nav1.8 blockers
BioWorld Science
Researchers from Jiangsu Hengrui Pharmaceuticals Co. Ltd. and Shanghai Hengrui Pharmaceutical Co. Ltd. have patented new sodium channel protein type 10 subunit α...
Hematopoietic stem cell research points to leukemia’s early roots
BioWorld Science
Hematopoietic stem cell (HSC) research over the past century has shown that leukemia may be driven by an invisible hand of inflammation. The bone marrow and...
News in brief
BioWorld Asia
BioWorld Asia briefs for April 7, 2026
Infinimmune presents preclinical data on anti-IL-22 antibody for atopic dermatitis
BioWorld Science
Infinimmune Inc. has recently presented results at the annual American Academy of Dermatology conference regarding their anti-IL-22 antibody IFX-101 for the...